As shown previously, there is a Elk-1 binding site in Egr-1 promoter [28], and in C6 glioma cells, ERβ-activated Egr-1 transcription is through ERK/Elk-1 pathway [29]. This evidence concerns the gene ESR2 and central nervous system cancer.